Consistent with the notion that intratumoral immune activity is an important prerequisite for sensitivity to PD1/PD-L1 checkpoint blockade (Topalian et al, 2012), we demonstrated that Ad5/11 expressing the trimeric MATE, but not the empty virus, effectively breaks tumor resistance to systemic application of a PD1 antibody. The gene discussed is CD274; the disease is neoplasm.